Serum immunoglobulin E in early childhood wheezing

Area of Science:

• Pediatrics
• Allergy and Immunology
• Respiratory Medicine

Background:

• Wheezing in infants is a common clinical presentation with diverse etiologies.
• Differentiating between transient viral-induced wheezing and early-onset asthma is clinically challenging.
• Serum immunoglobulin E (Ig E) is a key mediator in allergic inflammation.

Purpose of the Study:

• To investigate serum Ig E levels in children under 24 months presenting with wheezing.
• To assess the potential of serum Ig E as a predictive marker for asthma development.

Main Methods:

• A case-control study involving 38 wheezing children (cases) and 35 healthy controls.
• Cases were classified as bronchiolitis (first wheezing attack) or bronchial asthma (recurrent attacks with atopy history).
• Serum Ig E levels were quantified using an immune assay method.

Main Results:

• Mean serum Ig E levels were significantly higher in children with asthma compared to controls (p < 0.001).
• Serum Ig E levels were also elevated in bronchiolitis patients, though not statistically significant.
• Twenty-six percent of bronchiolitis patients exhibited Ig E levels above 1 standard deviation of the control mean, suggesting potential for future asthma.

Conclusions:

• Serum Ig E determination may aid in identifying infants with a first wheezing episode who are at risk for developing asthma.
• Elevated Ig E during the initial viral lower respiratory tract infection could be a potential marker for future recurrent wheezing.
• Long-term follow-up studies are necessary to confirm the predictive value of early elevated Ig E levels for asthma development.